- Home
- LTRN vs EDAP Comparison
LTRN vs EDAP Comparison
Compare LTRN & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- EDAP
- Stock Information
- Founded
- LTRN 2013
- EDAP 1979
- Country
- LTRN United States
- EDAP France
- Employees
- LTRN N/A
- EDAP N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LTRN Health Care
- EDAP Health Care
- Exchange
- LTRN Nasdaq
- EDAP Nasdaq
- Market Cap
- LTRN 49.9M
- EDAP 46.7M
- IPO Year
- LTRN 2020
- EDAP 1997
- Fundamental
- Price
- LTRN $4.00
- EDAP $2.40
- Analyst Decision
- LTRN Strong Buy
- EDAP Buy
- Analyst Count
- LTRN 1
- EDAP 3
- Target Price
- LTRN $25.00
- EDAP $8.50
- AVG Volume (30 Days)
- LTRN 177.8K
- EDAP 62.2K
- Earning Date
- LTRN 11-06-2025
- EDAP 11-06-2025
- Dividend Yield
- LTRN N/A
- EDAP N/A
- EPS Growth
- LTRN N/A
- EDAP N/A
- EPS
- LTRN N/A
- EDAP N/A
- Revenue
- LTRN N/A
- EDAP $74,008,221.00
- Revenue This Year
- LTRN N/A
- EDAP N/A
- Revenue Next Year
- LTRN N/A
- EDAP N/A
- P/E Ratio
- LTRN N/A
- EDAP N/A
- Revenue Growth
- LTRN N/A
- EDAP 1.56
- 52 Week Low
- LTRN $2.55
- EDAP $1.21
- 52 Week High
- LTRN $6.12
- EDAP $3.08
- Technical
- Relative Strength Index (RSI)
- LTRN 43.96
- EDAP 54.47
- Support Level
- LTRN $3.89
- EDAP $2.13
- Resistance Level
- LTRN $4.58
- EDAP $2.79
- Average True Range (ATR)
- LTRN 0.28
- EDAP 0.22
- MACD
- LTRN -0.04
- EDAP -0.01
- Stochastic Oscillator
- LTRN 18.44
- EDAP 49.34
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.